| Dear Doctor: |
| Welcome to Med School Forums, a dynamic and vibrant community of medical students worldwide who want to better themselves. You are currently viewing our boards as an Observer which only gives you limited access to discussions, articles and our other FREE features. By joining our free community you will be able to post topics, communicate privately with other members (PM), vote in polls, upload your own notes & photos, download notes created by other members and access many other special features. Registration is fast, simple and absolutely free so please, join our community today! If you have any problems with the registration process or your account login, please contact contact support. If you need more convincing, start browsing messages by clicking on the forum that you want to visit first from the selection below! |
|
|||||||
| Register | FAQ | Members List | Quiz | Search | Today's Posts | Mark Forums Read |
Tumbling motility, Gram positive rod:Spoiler for Answer:
|
| Medical News Discussion of the latest clinical trials and medicine in the media - any medical news that will impact on our practice. |
| Tags: accentia, biopharmaceuticals, chronic, drug, fast, fda, grants, help, sinunasetm, sinusitis, status, track |
![]() |
|
|
Thread Tools |
|
|
#1 |
|
Official Forum News Anchor
Join Date: Jan 2006
Posts: 4,185
|
Accentia Biopharmaceuticals, Inc. (Nasdaq:ABPI) has been notified that the U.S. Food and Drug Administration (FDA) granted Fast Track status to SinuNaseTM, the Company's intranasal Amphotericin B formulation. To the best of the Company's knowledge, SinuNase is the first and only drug candidate for chronic sinusitis (CS) to receive Fast Track status from the FDA... click link for more info.
Link To Original Article |
| OFF CALL |
|
![]() |
| Thread Tools | |
|
|
| > FDA Grants Accentia Biopharmaceuticals Fast Track Status For SinuNaseTM A Drug To Help Chronic Sinusitis |
|